JFL Life Sciences (NSE:JFLLIFE) FCF Margin % : 4.86% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is JFL Life Sciences FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. JFL Life Sciences's Free Cash Flow for the six months ended in Mar. 2024 was ₹22.6 Mil. JFL Life Sciences's Revenue for the six months ended in Mar. 2024 was ₹465.5 Mil. Therefore, JFL Life Sciences's FCF Margin % for the quarter that ended in Mar. 2024 was 4.86%.

As of today, JFL Life Sciences's current FCF Yield % is 3.98%.

The historical rank and industry rank for JFL Life Sciences's FCF Margin % or its related term are showing as below:

NSE:JFLLIFE' s FCF Margin % Range Over the Past 10 Years
Min: -23.16 Med: -4.97 Max: 4.86
Current: 4.86

During the past 6 years, the highest FCF Margin % of JFL Life Sciences was 4.86%. The lowest was -23.16%. And the median was -4.97%.

NSE:JFLLIFE's FCF Margin % is ranked better than
62.46% of 967 companies
in the Drug Manufacturers industry
Industry Median: 0.94 vs NSE:JFLLIFE: 4.86

JFL Life Sciences FCF Margin % Historical Data

The historical data trend for JFL Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JFL Life Sciences FCF Margin % Chart

JFL Life Sciences Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

1.44

-23.16

1.88

-21.18

4.86

JFL Life Sciences Semi-Annual Data
	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
FCF Margin %	Get a 7-Day Free Trial			1.44	-23.16	1.88	-21.18	4.86

Competitive Comparison of JFL Life Sciences's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, JFL Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JFL Life Sciences's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JFL Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where JFL Life Sciences's FCF Margin % falls into.

Save Embed

;

Save Embed

;

JFL Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

JFL Life Sciences's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	22.614	/	465.479
	=	4.86 %

JFL Life Sciences's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	22.614	/	465.479
	=	4.86 %

JFL Life Sciences FCF Margin % Related Terms

Thank you for viewing the detailed overview of JFL Life Sciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

JFL Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JFL Life Sciences Ltd (NSE:JFLLIFE) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015

Website

https://www.jfllifesciences.com

JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.

JFL Life Sciences Headlines

No Headlines